Duration of anti-tuberculous therapy in children with persistent tuberculomas

The usual treatment duration of tuberculomas recommended is 1 year. While anti-tuberculous therapy is of absolute necessity for the treatment of central nervous system tuberculosis, no clear guidelines exist regarding the duration of therapy in case of persistent tuberculomas. We present a series of...

Full description

Bibliographic Details
Main Authors: Ira Shah, Naman S Shetty
Format: Article
Language:English
Published: SAGE Publishing 2019-01-01
Series:SAGE Open Medical Case Reports
Online Access:https://doi.org/10.1177/2050313X18823092
id doaj-2a1bdc658bc84abab5c59562d44d6aa3
record_format Article
spelling doaj-2a1bdc658bc84abab5c59562d44d6aa32020-11-25T03:00:30ZengSAGE PublishingSAGE Open Medical Case Reports2050-313X2019-01-01710.1177/2050313X18823092Duration of anti-tuberculous therapy in children with persistent tuberculomasIra ShahNaman S ShettyThe usual treatment duration of tuberculomas recommended is 1 year. While anti-tuberculous therapy is of absolute necessity for the treatment of central nervous system tuberculosis, no clear guidelines exist regarding the duration of therapy in case of persistent tuberculomas. We present a series of six cases of children with central nervous system tuberculosis who received anti-tuberculous therapy for a period varying between 23 and 32 months depending on the resolution of lesion seen in neuroradiological scans of the patients. Decrease in number and size of granuloma were noted in all patients while one patient showed complete resolution. After stopping anti-tuberculous therapy, the size of the granuloma remained the same, while in one patient an increase was noted. Thus, the duration of anti-tuberculous therapy in patients with tuberculoma may vary and may be required for longer time based on treatment response.https://doi.org/10.1177/2050313X18823092
collection DOAJ
language English
format Article
sources DOAJ
author Ira Shah
Naman S Shetty
spellingShingle Ira Shah
Naman S Shetty
Duration of anti-tuberculous therapy in children with persistent tuberculomas
SAGE Open Medical Case Reports
author_facet Ira Shah
Naman S Shetty
author_sort Ira Shah
title Duration of anti-tuberculous therapy in children with persistent tuberculomas
title_short Duration of anti-tuberculous therapy in children with persistent tuberculomas
title_full Duration of anti-tuberculous therapy in children with persistent tuberculomas
title_fullStr Duration of anti-tuberculous therapy in children with persistent tuberculomas
title_full_unstemmed Duration of anti-tuberculous therapy in children with persistent tuberculomas
title_sort duration of anti-tuberculous therapy in children with persistent tuberculomas
publisher SAGE Publishing
series SAGE Open Medical Case Reports
issn 2050-313X
publishDate 2019-01-01
description The usual treatment duration of tuberculomas recommended is 1 year. While anti-tuberculous therapy is of absolute necessity for the treatment of central nervous system tuberculosis, no clear guidelines exist regarding the duration of therapy in case of persistent tuberculomas. We present a series of six cases of children with central nervous system tuberculosis who received anti-tuberculous therapy for a period varying between 23 and 32 months depending on the resolution of lesion seen in neuroradiological scans of the patients. Decrease in number and size of granuloma were noted in all patients while one patient showed complete resolution. After stopping anti-tuberculous therapy, the size of the granuloma remained the same, while in one patient an increase was noted. Thus, the duration of anti-tuberculous therapy in patients with tuberculoma may vary and may be required for longer time based on treatment response.
url https://doi.org/10.1177/2050313X18823092
work_keys_str_mv AT irashah durationofantituberculoustherapyinchildrenwithpersistenttuberculomas
AT namansshetty durationofantituberculoustherapyinchildrenwithpersistenttuberculomas
_version_ 1724697770505273344